Effects of a novel non-steroidal anti-inflammatory drug (M-5011) on bone metabolism in rats with collagen-induced arthritis

European Journal of Pharmacology

Volumn 352, Issue 1, 1998, Pages 81-90

  Murakami, Naofumi ^a   Takase, Hiroshi ^a   Saito, Takako ^a   Iwata, Kazumi ^a   Miura, Hiroaki ^a   Naruse, Tomohiro ^a  

^a Maruho Co   (Japan)

Author keywords

Bone mineral density; Collagen arthritis; NSAIDs (non steroidal anti inflammatory drugs); Pyridinoline

Indexed keywords

COLLAGEN; COLLAGEN ANTIBODY; DEOXYPYRIDINOLINE; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PYRIDINOLINE; S 2 [4 (3 METHYL 2 THIENYL)PHENYL]PROPIONIC ACID; TIAPROFENIC ACID; UNCLASSIFIED DRUG; ZALTOPROFEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; BONE ATROPHY; BONE DENSITY; BONE METABOLISM; BONE MINERAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ABSORPTIOMETRY, PHOTON; AMINO ACIDS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS; BONE AND BONES; BONE DENSITY; COLLAGEN; FEMALE; PHENYLPROPIONATES; RATS;

EID: 0031856241     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00342-2     Document Type: Article

References (33)

1. Aota, S., Nakamura, T., Suzuki, K., Tanaka, Y., Okazaki, Y., Segawa, Y., Miura, M., Kikuchi, S., 1996. Effects of indomethacin administration on bone turnover and bone mass in adjuvant-induced arthritis in rats. Calcif. Tissue Int. 59, 385-391.
2. Avoli, L.V., 1987. Osteoporosis in rheumatoid arthritis. Arthritis Rheum. 30, 830-831.
3. Bonnet, J., Zerath, E., Picaud, N., Lesur, C., Mattio, A., Tordjman, C., Hott, M., Marie, P.J., 1993. Bone morphometric changes in adjuvant-induced polyarthritic osteopenia in rats: evidence for an early bone formation defect. J. Bone Miner. Res. 8, 659-668.
4. Chang, Y.H., Pearson, C.M., Abe, C., 1980. Adjuvant polyarthritis: IV. Induction by a synthetic adjuvant: immunologic, histopathologic and other studies. Arthritis Rheum. 23, 62-71.
5. Courtenay, J.S., Dalimam, M.J., Dayan, A.D., Martin, A., Mosedale, B., 1980. Immunization against heterologous type II collagen-induced arthritis in mice. Nature 283, 666-668.
6. Delmas, P.D., Schlemmer, A., Gineytes, E., Riis, B., Chistiansen, C., 1991. Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis. J. Bone Miner. Res. 6, 639-644.
7. Fujimoto, M., Hayashida, K., Ochi, T., 1992. Fluctuation of interleukin-1 and -6 activity in bone marrow serum in collagen-induced arthritis in rats. Biomed. Res. 13, 243-251.
8. Ghosh, P., 1993. Nonsteroidal anti-inflammatory drugs and chondroprotection. A review of the evidence. Drugs 46, 834-846.
9. Griffiths, M.M., Eichwald, E.J., Martin, J.H., Smith, C.B., DeWitt, C.W., 1981. Immunogenetic control of experimental type II collagen-induced arthritis: I. Susceptibility and resistance among inbred strains of rats. Arthritis Rheum. 24, 781-789.
10. Jean-Pierre, P., Johnne, M.-P., Charles, J.M., 1994. Effects of non-steroidal and anti-inflammatory drugs and corticosteroids on cartilage metabolism in rheumatoid arthritis and osteoarthritis. In: Alan, J.L., Damiel, E.F. (Eds.), Nonsteroidal Anti-Inflammatory Drugs. Marcel Dekker, New York, NY, pp. 5-25.
11. Jones, S.M., Bhalla, A.K., 1993. Osteoporosis in rheumatoid arthritis. Clin. Exp. Rheumatol. 11, 557-562.
12. Kamada, H., Moritaka, G., Mastuura, S., Takaoka, Y., Nagai, H., 1997. Immunopharmacological studies on collagen-induced arthritis in Dark Agouti (DA) rats. Jpn. J. Pharmacol. 74, 313-322.
13. Kanemoto, Y., Tanaka, H., Tanaka, K., Imamura, K., Maruyama, F., Tsuboi, I., 1998. Effects of NSAIDs on interleukin-6 production. Jpn. J. Inflamm. 18, 139-145.
14. 2 on maintaining elevated proximal tibial metaphyseal cancellous bone mass in male rats. Calcif. Tissue Int. 50, 245-252.
15. Kido, H., Murakami, N., Ito, A., Kimura, K., Kodera, N., Doi, T., Naruse, T., 1998. Anti-inflammatory, analgesic and anti-pyretic effects of D-2-[4-(3-methyl-2-thienyl)phenyl]propionic acid (M-5011), a new non-steroidal anti-inflammatory drug, in rats and guinea pigs. Jpn. J. Pharmacol. 76, 75-86.
16. Leistein, J.C., Gaarde, W.A., Scholz, W., 1990. Interleukin-6 serum levels correlate with footpad swelling in adjuvant-induced arthritic Lewis rats treated with cyclosporin A or indomethacin. Clin. Immunol. Immunopathol. 56, 108-115.
17. Murakami, N., Takase, H., Tomita, T., Iwata, K., Naruse, T., 1996. Antinociceptive activity of a novel non-steroidal anti-inflammatory drug (M-5011) with low ulcerogenic effects in mice. Jpn. J. Pharmacol. 72, 29-37.
18. Pearson, C.M., Wood, F.D., 1959. Studies of polyarthritis and other lesions induced in rats by injection of mycobacterial adjuvant: I. General clinical and pathogenic characteristics and some modifying factors. Arthritis Rheum. 2, 440-459.
19. Raisz, L.G., Dietrich, J.W., Simmons, H.A., Seyberth, H.W., Hubbard, W., Oates, J.A., 1977. Effect of prostaglandin endoperoxides and metabolites on bone resorption in vitro. Nature 267, 532-534.
20. Segawa, Y., Nakamura, T., Aota, S., Tanaka, Y., Yoshida, K., Tsuzuki, N., Matsuda, K., 1995. Changes in urinary deoxypyridinoline level and vertebral bone mass in the development of adjuvant-induced arthritis in rats. Bone 17, 57-62.
21. Seibel, M.J., Duncan, A., Robins, S.P., 1989. Urinary hydroxy-pyridinium crosslinks provide indices of cartilage and bone involvement in arthritic diseases. J. Rheumatol. 16, 964-970.
22. Smith, R.J., Sly, L.M., 1996. Type II collagen induced arthritis in the diabetic-resistant biobreeding rat: inflammatory and histopathological features of joint pathology and effects of antiinflammatory and antirheumatic drugs on this chronic arthritic process. J. Pharmacol. Exp. Ther. 277, 1801-1813.
23. Stuart, J.M., Cremer, M.A., Townes, A.S., Kang, A.H., 1982. Type II collagen-induced arthritis in rat: passive transfer with serum and evidence that IgG antibodies can cause arthritis. J. Exp. Med. 155, 1-16.
24. Sugita, T., Furukawa, O., Ueno, M., Murakami, T., Takata, I., Tosa, T., 1993. Enhanced expression of interleukin-6 in rat and murine arthritis models. Int. J. Immunopharmacol. 15, 469-476.
25. 2 stimulates bone formation both in the bone marrow and in the periosteum. Endocrinol. J. 42, 323-330.
26. 2 femoral bone mineral density in ovariectomized rats. Calcif. Tissue Int. 52, 442-446.
27. Tashijian, A.M. Jr., Tice, J.E., Sides, K., 1977. Biological activities of prostaglandin analogues and metabolites on bone in organ culture. Nature 266, 645-647.
28. Theisen-Popp, P., Pape, H., Muller-Peddinghaus, R., 1992. Interleukin-6 (IL-6) in adjuvant arthritis of rats and its pharmacological modulation. Int. J. Immunopharmacol. 14, 565-571.
29. Trentham, D.E., Townes, A.S., Kang, A.H., 1977. Autoimmunity to type II collagen; an experimental model of arthritis. J. Exp. Med. 146, 857-868.
30. Utsunomiya, I., Nagai, S., Oh-ishi, S., 1994. Differential effects of indomethacin and dexamethasone on cytokine production in carrageenin-induced rat pleurisy. Eur. J. Pharmacol. 252, 213-218.
31. Vingsbo, C., Jonsson, R., Holmdahl, R., 1995. Avidine-induced arthritis in rats: a T cell-dependent chronic disease influenced both by MHC genes and by non-MHC genes. Clin. Exp. Immunol. 99, 359-363.
32. Whittle, B.J.R., 1981. Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in rats. Gastroenterology 80, 94-98.
33. Woolf, A.D., 1991. Osteoporosis in rheumatoid arthritis - the clinical viewpoint. Br. J. Rheumatol. 30, 82-84.